Todd D Gould

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Molecular psychiatry

Proceedings of the National Academy of Sciences of the United States of America

Journal of psychopharmacology (Oxford, England)

Translational psychiatry

University of Maryland School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Maryland School of Medicine

United States

Associate Professor :: Psychiatry

Publications

Kyle A Brown, Todd D Gould
Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular psychiatry (2024)
Kyle A Brown, Todd D Gould
Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular psychiatry (2024)
Kyle A Brown, Todd D Gould
Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular psychiatry 29 (4) (2024)
Kyle A Brown, Todd D Gould
Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular psychiatry (2024)
Kyle A Brown, Todd D Gould
Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular psychiatry (2024)
Kyle A Brown, Todd D Gould
Targeting metaplasticity mechanisms to promote sustained antidepressant actions. Molecular psychiatry 29 (4) (2024)
Kyle A Brown, Todd D Gould
Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2023)
Ruin Moaddel, Panos Zanos, Cristan A Farmer, Bashkim Kadriu, Patrick J Morris, Jacqueline Lovett, Elia E Acevedo-Diaz, Grace W Cavanaugh, Peixiong Yuan, Mani Yavi, Craig J Thomas, Lawrence T Park, Luigi Ferrucci, Todd D Gould, Carlos A Zarate
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration. Translational psychiatry 12 (1) (2022)
Jaclyn N Highland, Patrick J Morris, Kylie M Konrath, Lace M Riggs, Natalie R Hagen, Panos Zanos, Chris F Powels, Ruin Moaddel, Craig J Thomas, Amy Q Wang, Todd D Gould
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2 , 6)- and (5 R )-Methyl-(2 R, 6 R )-hydroxynorketamines. ACS chemical neuroscience 13 (4) (2022)
Polymnia Georgiou, Panos Zanos, Ta-Chung M Mou, Xiaoxian An, Danielle M Gerhard, Dilyan I Dryanovski, Liam E Potter, Jaclyn N Highland, Carleigh E Jenne, Brent W Stewart, Katherine J Pultorak, Peixiong Yuan, Chris F Powels, Jacqueline Lovett, Edna F R Pereira, Sarah M Clark, Leonardo H Tonelli, Ruin Moaddel, Carlos A Zarate, Ronald S Duman, Scott M Thompson, Todd D Gould
Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor. Nature neuroscience 25 (9) (2022)
Lace M Riggs, Xiaoxian An, Edna F R Pereira, Todd D Gould
(R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency. Translational psychiatry 11 (1) (2021)
Jaclyn N Highland, Cristan A Farmer, Panos Zanos, Jacqueline Lovett, Carlos A Zarate, Ruin Moaddel, Todd D Gould
Sex-dependent metabolism of ketamine and ( 2R,6R )-hydroxynorketamine in mice and humans. Journal of psychopharmacology (Oxford, England) 36 (2) (2021)
Eric W Lumsden, Timothy A Troppoli, Scott J Myers, Panos Zanos, Yasco Aracava, Jan Kehr, Jacqueline Lovett, Sukhan Kim, Fu-Hua Wang, Staffan Schmidt, Carleigh E Jenne, Peixiong Yuan, Patrick J Morris, Craig J Thomas, Carlos A Zarate, Ruin Moaddel, Stephen F Traynelis, Edna F R Pereira, Scott M Thompson, Edson X Albuquerque, Todd D Gould
Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America 116 (11) (2019)
Panos Zanos, Jaclyn N Highland, Xin Liu, Timothy A Troppoli, Polymnia Georgiou, Jacqueline Lovett, Patrick J Morris, Brent W Stewart, Craig J Thomas, Scott M Thompson, Ruin Moaddel, Todd D Gould
(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses. British journal of pharmacology 176 (14) (2019)
Panos Zanos, Jaclyn N Highland, Brent W Stewart, Polymnia Georgiou, Carleigh E Jenne, Jacqueline Lovett, Patrick J Morris, Craig J Thomas, Ruin Moaddel, Carlos A Zarate, Todd D Gould
(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions. Proceedings of the National Academy of Sciences of the United States of America 116 (13) (2019)
Samuel R Krimmel, Panos Zanos, Polymnia Georgiou, Luana Colloca, Todd D Gould
Classical conditioning of antidepressant placebo effects in mice. Psychopharmacology 237 (1) (2019)
Jaclyn N Highland, Patrick J Morris, Panos Zanos, Jacqueline Lovett, Soumita Ghosh, Amy Q Wang, Carlos A Zarate, Craig J Thomas, Ruin Moaddel, Todd D Gould
Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine. Journal of psychopharmacology (Oxford, England) 33 (1) (2018)

Todd D Gould.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Todd D Gould